OL

Olio Labs

YC S23

Founded 2023 · 5 employees · 2 known investors

oliolabs.co ↗

Olio Labs develops drug combination therapies using machine learning to identify treatments that target multiple interacting proteins simultaneously, with initial candidates focused on obesity treatment. The company aims to create pharmaceutical solutions that achieve greater efficacy and lower side effect profiles than existing single-target medications.

Founders & leadership· Y Combinator alumni (S23)

David Tingleyin𝕏Founder

Tom Roseberryin𝕏Founder

Investors · 2

OV

Overwater Ventures LlcPalo Alto · $500K – $2M

Y

Y CombinatorMountain View · $500K – $500K